Quantumzyme Corp. (QTZM)

Quantumzyme Income Statement

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Oct 31, 2025	Jul 31, 2025	Jul 31, 2024
Selling, General & Admin	0.16	0.18	0.16
Operating Expenses	0.16	0.18	0.16
Operating Income	-0.16	-0.18	-0.16
Interest Expense	-0.03	-0.02	-0.01
EBT Excluding Unusual Items	-0.19	-0.2	-0.18
Other Unusual Items	0	0	-
Pretax Income	-0.18	-0.2	-0.18
Net Income	-0.18	-0.2	-0.18
Net Income to Common	-0.18	-0.2	-0.18
Shares Outstanding (Basic)	36	35	35
Shares Outstanding (Diluted)	36	35	35
Shares Change (YoY)	-	1.08%	-
EPS (Basic)	-0.01	-0.01	-0.01
EPS (Diluted)	-0.01	-0.01	-0.01
EBIT	-0.16	-0.18	-0.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.